Accessories & eyewear specialist Bollé Brands has launched a new RX program to allow European and American consumers to access its proprietary lens technologies, adapted to their eyesight.
According to the company, the idea behind this launch goes beyond the prescription offering itself. Bollé’s objective is to offer a complete service to its partners. It will also introduce two new optical collections in the coming weeks under the Bollé and Serengeti brands.
A company release noted.. ‘From September 26th, from a single platform available worldwide, our partners will have access to all the group’s brands and will be able to offer their customers the benefits of all the proprietary and exclusive technologies of the Bollé Brands group.
‘This will enable opticians to offer the best of the best in terms of sun lenses on the market today: Bollé’s photochromic Phantom lens, Bollé’s Volt+ lens that has developed with the help of artificial intelligence, Spy+’s Happy Boost, as well as our signature Serengeti mineral lens (photochromic, polarising and Spectral Control technologies). This exclusive program also offers the widest prescription grid in the industry (- 8 / + 6).’
Damien Hars, Bollé Brands’ Vice President Digital, said “The process of manufacturing a pair of glasses adapted to the eyesight is complex and requires the intervention of highly qualified personnel, in an increasingly restricted timeframe to satisfy the requirements of consumers.
“We offer our optician partners a turnkey tool that allows them to respond quickly to customer requests, via an intuitive data entry interface, and to follow all the steps of the product manufacturing process. The web platform will be enriched in the coming months with new features to meet market trends.”
